Drug major Merck & Co., Inc. (MRK) announced Wednesday that the U.S. Food and Drug Administration has approved its anti-PD-1 therapy ...
Scientists at Stanford University conducted an experiment using a common food dye found in the popular snack Doritos to turn the skin of mice transparent.(Representational Image) The experiment ...
The results come from a Phase 3 trial pitting a drug from biotech Summit Therapeutics against Merck & Co.’s Keytruda in people recently diagnosed with advanced non-small cell lung cancer.
Merck’s Keytruda Combo for Urothelial Carcinoma Gets EU Approval: The European Commission granted approval to Merck’s Keytruda in combination with Astellas/Pfizer’s antibody-drug conjugate ...
By creating more effective, transparent ad transactions, DV strengthens the digital advertising ecosystem, ensuring a fair value exchange between buyers and sellers of digital media.
Mitchell Kapoor has given his Buy rating due to a combination of factors surrounding the potential of Summit Therapeutics’ drug ivonescimab, particularly in the wake of Merck’s KEYTRUDA failures.
There are three ways to make image backgrounds transparent on Mac: Using Remove background in Tools, Instant Alpha, and Selection tools. Before following any of the methods given below, make a ...
It is going to look a little bizarre, but there is a great reason behind the change… Nike have changed their logo on third kits to celebrate women's football. They explained their switch for ...
Merck MRK decided to discontinue two separate phase III studies, KEYNOTE-867 and KEYNOTE-630, evaluating its blockbuster drug Keytruda in patients with certain types of lung cancer and skin cancer ...
A Reddit thread started Thursday titled, "What's wrong with the Facebook logo?" shows a blue lowercase "f" on a black background instead of a blue background with a white "f." Some users who have ...
London: Merck has stopped two separate late-stage studies of its immunotherapy Keytruda in patients with skin and lung cancers, the company said on Thursday, marking the latest set of trial ...